Hosted on MSN9mon
Amgen’s obesity drug puts stock on pace for best day since 2009 as analysts predict big gains to comeFueled by upbeat management comments on an experimental obesity treatment, Amgen’s stock was on pace early Friday for its best day since 2009 — and analysts see more gains ahead as the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback